Ubatay, Marife M.
HRN: 20-39-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2024
CEFUROXIME 1.5GM (VIAL)
03/09/2024
03/09/2024
IV
1.5
On Call To OR
For Cervical Polypectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes